Skip to main content

FDA recall, , Moderate risk

Helena Laboratories V8 Serum Protein SPE Kit

The V8 Serum Protein SPE Kit's diluent shows a reproducible shift in quality control results relative to historical or comparator diluent.

What happened

Helena Laboratories, Corp., of Beaumont, Texas, is recalling its V8 Serum Protein SPE Kit. The company started the recall on its own, beginning September 14, 2026. Assayed quality control material run with kits manufactured using a diluent lot shows a reproducible shift in serum protein electrophoretic fraction distribution.

Compared with historical or comparator diluent lots, decreased albumin is approximately 6 to 10 relative percentage points. Increased beta and gamma globulin fractions are approximately 1 to 3 relative percentage points.

The affected diluent is V8 SPE Diluent, a component of the finished kit. Distribution was worldwide, with US nationwide distribution in California, Florida, Indiana, Michigan, Mississippi, Missouri, Tennessee and Texas. The Food and Drug Administration added the recall to its Enforcement Report on November 17, 2026.

What to do

If a code on your device is listed below:

  1. Check the lot against the recall notice and ask your provider or supplier before you stop using it.

Typical advice for a recalled medical device; the FDA notice gives no product-specific instructions.

Is your kit affected?

Compare every listed detail under your product with its label.

  1. V8 Serum Protein SPE Kit, Cat. No.: 1805, containing V8 SPE Diluent

    Model number
    • 552512
    Product code
    • 552512
    Other code
    • M52518050
    Lot code
    • 4-26-1805
    • 3-26-552512

Recall details

Posted by FDA
Recall began
Status
Open
Sold in

Distributed in Michigan, California, Tennessee, Mississippi, Missouri, Texas, Indiana and Florida, and in Paraguay, Canada, Israel, the Philippines and Trinidad and Tobago.

Recalled by
Helena Laboratories, Corp.Beaumont, Texas
Risk

Moderate risk

Using it may cause short-term health problems, or ones that treatment can reverse. Serious harm is unlikely.

FDA Class II recall · How risk is rated

FDA event number
99987
Recall number
Z-0469-2027
Recall type
Started by the company

All recalls from Helena Laboratories, Corp.

Timeline

FDA's Enforcement Report is its public list of recalls; FDA posts a recall by adding it there.

  1. Helena Laboratories began the recall

  2. FDA posted the recall to its Enforcement Report and rated it Class II (moderate risk)

  3. Added to Recall Canary

Summary by Recall Canary, written with AI · summary updated Nov 19, 2026 · primary source: U.S. Food and Drug Administration (opens in a new tab) recall · cite: “Helena Laboratories V8 Serum Protein SPE Kit Recall.” Recall Canary. https://recallcanary.com/recall/fda/helena-laboratories-v8-serum-protein-spe-kit-cat-no.